 Ram Nagaraj
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lens, Crystalline | 51 | 2024 | 122 | 13.610 |
Why?
| | Glycation End Products, Advanced | 35 | 2025 | 76 | 8.160 |
Why?
| | Crystallins | 32 | 2025 | 59 | 7.760 |
Why?
| | Lysine | 30 | 2025 | 286 | 5.330 |
Why?
| | Pyruvaldehyde | 27 | 2025 | 43 | 4.890 |
Why?
| | Cataract | 24 | 2024 | 208 | 4.760 |
Why?
| | Epithelial Cells | 17 | 2024 | 1065 | 4.380 |
Why?
| | Molecular Chaperones | 18 | 2022 | 182 | 4.270 |
Why?
| | alpha-Crystallin B Chain | 12 | 2020 | 24 | 4.090 |
Why?
| | Epithelial-Mesenchymal Transition | 7 | 2021 | 202 | 3.570 |
Why?
| | Transforming Growth Factor beta2 | 6 | 2021 | 35 | 3.360 |
Why?
| | alpha-Crystallin A Chain | 8 | 2020 | 13 | 3.100 |
Why?
| | Kynurenine | 11 | 2016 | 114 | 3.020 |
Why?
| | Arginine | 22 | 2020 | 265 | 2.810 |
Why?
| | Presbyopia | 4 | 2023 | 14 | 2.460 |
Why?
| | Apoptosis | 13 | 2019 | 2503 | 2.350 |
Why?
| | Maillard Reaction | 24 | 2015 | 25 | 2.330 |
Why?
| | Lens Capsule, Crystalline | 3 | 2024 | 11 | 2.140 |
Why?
| | Capsule Opacification | 4 | 2020 | 22 | 1.950 |
Why?
| | Eye Proteins | 6 | 2018 | 88 | 1.850 |
Why?
| | Glaucoma | 3 | 2022 | 219 | 1.830 |
Why?
| | alpha-Crystallins | 7 | 2019 | 13 | 1.810 |
Why?
| | Aging | 18 | 2020 | 1776 | 1.740 |
Why?
| | Ocular Hypertension | 3 | 2025 | 66 | 1.730 |
Why?
| | HSP27 Heat-Shock Proteins | 4 | 2015 | 13 | 1.640 |
Why?
| | Diabetes Mellitus, Experimental | 10 | 2020 | 182 | 1.490 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 8 | 2018 | 56 | 1.470 |
Why?
| | Cysteine | 3 | 2025 | 195 | 1.450 |
Why?
| | Peptides | 5 | 2021 | 925 | 1.400 |
Why?
| | Ascorbic Acid | 9 | 2017 | 120 | 1.390 |
Why?
| | Glyoxal | 3 | 2025 | 14 | 1.340 |
Why?
| | Ornithine | 10 | 2017 | 26 | 1.310 |
Why?
| | Receptor for Advanced Glycation End Products | 3 | 2021 | 31 | 1.270 |
Why?
| | Sirtuins | 2 | 2019 | 39 | 1.260 |
Why?
| | Sirtuin 3 | 2 | 2019 | 58 | 1.210 |
Why?
| | Cellular Senescence | 3 | 2024 | 181 | 1.130 |
Why?
| | Glutathione | 10 | 2020 | 348 | 1.110 |
Why?
| | Acetylation | 9 | 2024 | 246 | 1.070 |
Why?
| | Retinal Ganglion Cells | 4 | 2025 | 97 | 1.070 |
Why?
| | Cattle | 23 | 2020 | 977 | 1.050 |
Why?
| | Animals | 60 | 2025 | 35346 | 1.040 |
Why?
| | Chromatography, Liquid | 8 | 2024 | 423 | 1.010 |
Why?
| | Imidazoles | 7 | 2012 | 234 | 0.980 |
Why?
| | Antibodies, Monoclonal | 6 | 2019 | 1367 | 0.940 |
Why?
| | Tandem Mass Spectrometry | 7 | 2024 | 524 | 0.920 |
Why?
| | Pyrimidines | 10 | 2017 | 459 | 0.890 |
Why?
| | Sulfhydryl Compounds | 2 | 2024 | 187 | 0.850 |
Why?
| | Ultraviolet Rays | 3 | 2017 | 382 | 0.840 |
Why?
| | Tetroses | 3 | 2020 | 5 | 0.820 |
Why?
| | Blotting, Western | 13 | 2019 | 1205 | 0.820 |
Why?
| | Eye Diseases | 2 | 2015 | 80 | 0.780 |
Why?
| | Diabetic Retinopathy | 3 | 2021 | 176 | 0.770 |
Why?
| | Mice | 20 | 2023 | 16935 | 0.770 |
Why?
| | Protein Processing, Post-Translational | 5 | 2024 | 455 | 0.760 |
Why?
| | Lactoylglutathione Lyase | 5 | 2009 | 17 | 0.740 |
Why?
| | Glycosylation | 10 | 2020 | 150 | 0.730 |
Why?
| | Chromatography, High Pressure Liquid | 18 | 2010 | 582 | 0.730 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4061 | 0.710 |
Why?
| | Humans | 81 | 2025 | 129378 | 0.700 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.680 |
Why?
| | Kynurenic Acid | 1 | 2020 | 19 | 0.680 |
Why?
| | Cells, Cultured | 14 | 2024 | 4082 | 0.670 |
Why?
| | Glucose | 10 | 2017 | 1002 | 0.670 |
Why?
| | Posterior Capsule of the Lens | 1 | 2020 | 11 | 0.670 |
Why?
| | Malonates | 1 | 2019 | 8 | 0.660 |
Why?
| | Propionates | 1 | 2019 | 37 | 0.650 |
Why?
| | Heat-Shock Proteins | 4 | 2022 | 136 | 0.650 |
Why?
| | Proteins | 6 | 2021 | 940 | 0.630 |
Why?
| | Tryptophan | 7 | 2013 | 179 | 0.620 |
Why?
| | Retinal Vessels | 4 | 2018 | 65 | 0.590 |
Why?
| | Aged | 29 | 2024 | 22052 | 0.570 |
Why?
| | Spectrometry, Fluorescence | 9 | 2012 | 171 | 0.560 |
Why?
| | Reperfusion Injury | 1 | 2020 | 272 | 0.560 |
Why?
| | Fibronectins | 3 | 2021 | 123 | 0.550 |
Why?
| | Lipid Bilayers | 2 | 2010 | 98 | 0.550 |
Why?
| | Cell Line | 7 | 2020 | 2780 | 0.540 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 337 | 0.540 |
Why?
| | Immunohistochemistry | 7 | 2019 | 1698 | 0.530 |
Why?
| | Aspirin | 1 | 2020 | 380 | 0.530 |
Why?
| | MAP Kinase Signaling System | 2 | 2018 | 312 | 0.520 |
Why?
| | Circular Dichroism | 6 | 2019 | 148 | 0.520 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 274 | 0.510 |
Why?
| | Proteomics | 2 | 2024 | 1062 | 0.480 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 11 | 2018 | 833 | 0.480 |
Why?
| | Protein Aggregation, Pathological | 1 | 2015 | 16 | 0.480 |
Why?
| | HSP20 Heat-Shock Proteins | 1 | 2015 | 2 | 0.480 |
Why?
| | Protein Structure, Tertiary | 7 | 2013 | 838 | 0.470 |
Why?
| | Pyridoxamine | 2 | 2006 | 2 | 0.470 |
Why?
| | Mice, Inbred C57BL | 7 | 2023 | 5438 | 0.470 |
Why?
| | Pericytes | 2 | 2005 | 28 | 0.460 |
Why?
| | Histones | 1 | 2020 | 588 | 0.460 |
Why?
| | Cross-Linking Reagents | 9 | 2020 | 205 | 0.450 |
Why?
| | Protein Structure, Secondary | 6 | 2013 | 341 | 0.450 |
Why?
| | Endothelial Cells | 3 | 2018 | 748 | 0.440 |
Why?
| | Blood Proteins | 8 | 2009 | 242 | 0.440 |
Why?
| | Brain Diseases | 1 | 2015 | 137 | 0.430 |
Why?
| | Amino Acid Sequence | 8 | 2015 | 2058 | 0.430 |
Why?
| | Fibrosis | 1 | 2016 | 520 | 0.420 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 45 | 0.410 |
Why?
| | Rats | 12 | 2025 | 5497 | 0.400 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2013 | 186 | 0.400 |
Why?
| | Solubility | 3 | 2023 | 235 | 0.400 |
Why?
| | Mice, Knockout | 5 | 2020 | 2870 | 0.400 |
Why?
| | Disulfides | 2 | 2023 | 97 | 0.400 |
Why?
| | Intraocular Pressure | 3 | 2025 | 297 | 0.390 |
Why?
| | Diabetes Mellitus | 10 | 2021 | 999 | 0.390 |
Why?
| | Mass Spectrometry | 6 | 2019 | 716 | 0.390 |
Why?
| | Paraffin Embedding | 2 | 2024 | 29 | 0.390 |
Why?
| | Protein Conformation | 7 | 2019 | 857 | 0.390 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2018 | 329 | 0.380 |
Why?
| | Interferon-gamma | 3 | 2018 | 770 | 0.380 |
Why?
| | Middle Aged | 24 | 2024 | 31102 | 0.370 |
Why?
| | Organ Culture Techniques | 5 | 2019 | 154 | 0.370 |
Why?
| | Water | 3 | 2023 | 446 | 0.370 |
Why?
| | Retina | 3 | 2025 | 279 | 0.370 |
Why?
| | Caspase 3 | 5 | 2013 | 245 | 0.360 |
Why?
| | HeLa Cells | 4 | 2016 | 608 | 0.360 |
Why?
| | Citrate (si)-Synthase | 4 | 2020 | 57 | 0.360 |
Why?
| | Protein Binding | 6 | 2020 | 2121 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2010 | 12 | 0.350 |
Why?
| | Aquaporins | 1 | 2010 | 8 | 0.350 |
Why?
| | Caspase 9 | 4 | 2013 | 56 | 0.340 |
Why?
| | Myristic Acid | 2 | 2010 | 10 | 0.330 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2010 | 85 | 0.330 |
Why?
| | Protein Denaturation | 4 | 2020 | 75 | 0.330 |
Why?
| | Membrane Lipids | 1 | 2010 | 91 | 0.330 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2010 | 182 | 0.330 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2548 | 0.320 |
Why?
| | Actins | 3 | 2020 | 411 | 0.310 |
Why?
| | Protein Folding | 1 | 2010 | 266 | 0.300 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2831 | 0.290 |
Why?
| | Structure-Activity Relationship | 4 | 2015 | 548 | 0.290 |
Why?
| | gamma-Crystallins | 2 | 2020 | 3 | 0.290 |
Why?
| | Capillaries | 2 | 2005 | 103 | 0.280 |
Why?
| | Pyrroles | 5 | 2009 | 202 | 0.280 |
Why?
| | Cloning, Molecular | 4 | 2010 | 524 | 0.280 |
Why?
| | Reactive Oxygen Species | 7 | 2018 | 596 | 0.280 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 287 | 0.270 |
Why?
| | Rats, Sprague-Dawley | 6 | 2015 | 2406 | 0.270 |
Why?
| | Cricetulus | 3 | 2013 | 107 | 0.270 |
Why?
| | Lens Diseases | 1 | 2006 | 2 | 0.270 |
Why?
| | CHO Cells | 3 | 2013 | 153 | 0.270 |
Why?
| | Aldehyde Reductase | 3 | 2006 | 28 | 0.260 |
Why?
| | Cricetinae | 3 | 2013 | 277 | 0.260 |
Why?
| | Endothelium, Vascular | 2 | 2004 | 901 | 0.260 |
Why?
| | Adult | 21 | 2020 | 35512 | 0.260 |
Why?
| | Dipeptides | 1 | 2005 | 49 | 0.250 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 2011 | 0.250 |
Why?
| | Cytokines | 1 | 2013 | 2015 | 0.250 |
Why?
| | Quinoxalines | 1 | 2005 | 65 | 0.240 |
Why?
| | Cell Cycle | 1 | 2008 | 592 | 0.240 |
Why?
| | Alkylation | 1 | 2025 | 25 | 0.240 |
Why?
| | GAP-43 Protein | 1 | 2025 | 6 | 0.240 |
Why?
| | Synapsins | 1 | 2025 | 13 | 0.240 |
Why?
| | Histidine | 1 | 2005 | 60 | 0.240 |
Why?
| | Serum Albumin | 2 | 2008 | 149 | 0.240 |
Why?
| | Cell-Penetrating Peptides | 1 | 2025 | 21 | 0.230 |
Why?
| | Mice, Inbred BALB C | 3 | 2019 | 1245 | 0.230 |
Why?
| | Diabetes Complications | 1 | 2006 | 224 | 0.230 |
Why?
| | Protein Transport | 3 | 2015 | 428 | 0.230 |
Why?
| | Down-Regulation | 3 | 2013 | 636 | 0.230 |
Why?
| | Acetyl Coenzyme A | 1 | 2024 | 5 | 0.230 |
Why?
| | Protein Aggregates | 2 | 2015 | 67 | 0.220 |
Why?
| | Mutation | 3 | 2015 | 3717 | 0.220 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2025 | 141 | 0.220 |
Why?
| | Formaldehyde | 1 | 2024 | 60 | 0.220 |
Why?
| | Enzyme Activation | 3 | 2010 | 811 | 0.220 |
Why?
| | Protein Kinase C | 1 | 2005 | 259 | 0.220 |
Why?
| | Neuroprotective Agents | 1 | 2025 | 122 | 0.220 |
Why?
| | Molecular Structure | 5 | 2012 | 481 | 0.220 |
Why?
| | Magnetic Resonance Spectroscopy | 6 | 2007 | 539 | 0.210 |
Why?
| | Calmodulin | 1 | 2003 | 76 | 0.210 |
Why?
| | Axonal Transport | 2 | 2022 | 26 | 0.210 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2003 | 77 | 0.210 |
Why?
| | Proline | 1 | 2003 | 76 | 0.210 |
Why?
| | Amine Oxidase (Copper-Containing) | 1 | 2002 | 5 | 0.200 |
Why?
| | Imidazolidines | 2 | 1994 | 10 | 0.200 |
Why?
| | Neuroprotection | 1 | 2022 | 38 | 0.200 |
Why?
| | Temperature | 2 | 2020 | 634 | 0.200 |
Why?
| | Galactosemias | 2 | 1994 | 15 | 0.200 |
Why?
| | Ribose | 3 | 2017 | 22 | 0.200 |
Why?
| | Oxidation-Reduction | 2 | 2017 | 1033 | 0.190 |
Why?
| | Age Factors | 4 | 2019 | 3144 | 0.190 |
Why?
| | Capsulorhexis | 1 | 2021 | 8 | 0.190 |
Why?
| | Cytochromes c | 2 | 2013 | 60 | 0.190 |
Why?
| | Signal Transduction | 4 | 2021 | 4924 | 0.190 |
Why?
| | Lipids | 1 | 2005 | 625 | 0.190 |
Why?
| | Oxidative Stress | 2 | 2005 | 1269 | 0.180 |
Why?
| | Beer | 1 | 2001 | 7 | 0.180 |
Why?
| | Recombinant Proteins | 3 | 2012 | 1304 | 0.180 |
Why?
| | Acetone | 1 | 2001 | 12 | 0.180 |
Why?
| | Epitopes | 2 | 2005 | 470 | 0.180 |
Why?
| | Models, Molecular | 4 | 2017 | 1489 | 0.180 |
Why?
| | Malate Dehydrogenase | 1 | 2020 | 1 | 0.180 |
Why?
| | Fluorescence | 5 | 2015 | 159 | 0.180 |
Why?
| | Anti-Infective Agents | 1 | 2003 | 246 | 0.180 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2015 | 361 | 0.170 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 284 | 0.170 |
Why?
| | Amino Acids | 3 | 2017 | 483 | 0.170 |
Why?
| | Diabetic Angiopathies | 1 | 2002 | 261 | 0.170 |
Why?
| | Norleucine | 3 | 1996 | 3 | 0.170 |
Why?
| | Phosphorylation | 5 | 2010 | 1713 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2020 | 87 | 0.160 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 100 | 0.160 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2002 | 443 | 0.160 |
Why?
| | Mice, Transgenic | 3 | 2010 | 2119 | 0.160 |
Why?
| | Adolescent | 10 | 2020 | 20378 | 0.160 |
Why?
| | Oxalates | 1 | 1999 | 10 | 0.160 |
Why?
| | Blood Glucose | 3 | 2021 | 2096 | 0.160 |
Why?
| | Aged, 80 and over | 10 | 2015 | 7069 | 0.160 |
Why?
| | Thermodynamics | 2 | 2012 | 407 | 0.160 |
Why?
| | Antibody Specificity | 3 | 2009 | 184 | 0.160 |
Why?
| | Multiprotein Complexes | 1 | 2020 | 154 | 0.160 |
Why?
| | Succinates | 1 | 2019 | 23 | 0.160 |
Why?
| | Membrane Proteins | 2 | 2019 | 1119 | 0.160 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 146 | 0.160 |
Why?
| | Cytosol | 1 | 2019 | 218 | 0.160 |
Why?
| | Gain of Function Mutation | 1 | 2019 | 34 | 0.160 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 939 | 0.150 |
Why?
| | Young Adult | 4 | 2020 | 12415 | 0.150 |
Why?
| | Retinal Degeneration | 1 | 2018 | 37 | 0.140 |
Why?
| | Male | 12 | 2025 | 63595 | 0.140 |
Why?
| | Binding Sites | 2 | 2012 | 1252 | 0.140 |
Why?
| | CD55 Antigens | 1 | 2017 | 29 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1641 | 0.140 |
Why?
| | Collagen | 3 | 1996 | 434 | 0.140 |
Why?
| | Antioxidants | 2 | 2015 | 559 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2019 | 248 | 0.140 |
Why?
| | Calcium | 1 | 2003 | 1209 | 0.140 |
Why?
| | Dura Mater | 2 | 1996 | 30 | 0.130 |
Why?
| | Deoxyglucose | 2 | 1996 | 52 | 0.130 |
Why?
| | Snail Family Transcription Factors | 1 | 2016 | 18 | 0.130 |
Why?
| | Basement Membrane | 1 | 2016 | 31 | 0.130 |
Why?
| | Smad3 Protein | 1 | 2016 | 43 | 0.130 |
Why?
| | Monosaccharides | 3 | 2003 | 12 | 0.130 |
Why?
| | Smad2 Protein | 1 | 2016 | 38 | 0.130 |
Why?
| | Caproates | 1 | 1995 | 4 | 0.130 |
Why?
| | Smad4 Protein | 1 | 2016 | 38 | 0.130 |
Why?
| | Spectrophotometry | 3 | 2005 | 58 | 0.130 |
Why?
| | Models, Chemical | 3 | 2005 | 265 | 0.120 |
Why?
| | Microscopy, Fluorescence | 2 | 2008 | 400 | 0.120 |
Why?
| | Selenious Acid | 1 | 2015 | 3 | 0.120 |
Why?
| | Binding, Competitive | 3 | 2008 | 206 | 0.120 |
Why?
| | Photobleaching | 1 | 2015 | 23 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2010 | 431 | 0.120 |
Why?
| | Injections, Intraperitoneal | 1 | 2015 | 111 | 0.120 |
Why?
| | Models, Biological | 3 | 2010 | 1719 | 0.110 |
Why?
| | Dimerization | 2 | 2007 | 192 | 0.110 |
Why?
| | Stereoisomerism | 2 | 2005 | 99 | 0.110 |
Why?
| | Caspases | 2 | 2006 | 245 | 0.110 |
Why?
| | Heat-Shock Response | 1 | 2015 | 72 | 0.110 |
Why?
| | RNA, Messenger | 2 | 2016 | 2707 | 0.110 |
Why?
| | Glycoproteins | 1 | 1996 | 338 | 0.110 |
Why?
| | Peroxynitrous Acid | 1 | 2013 | 14 | 0.110 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2013 | 48 | 0.110 |
Why?
| | Glycine | 1 | 2014 | 164 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 2 | 2010 | 637 | 0.110 |
Why?
| | Time Factors | 5 | 2006 | 6550 | 0.110 |
Why?
| | Cell Movement | 1 | 2018 | 945 | 0.110 |
Why?
| | Algorithms | 1 | 2021 | 1620 | 0.110 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2013 | 171 | 0.100 |
Why?
| | Flow Cytometry | 2 | 2008 | 1156 | 0.100 |
Why?
| | RNA | 1 | 2019 | 883 | 0.100 |
Why?
| | Enzyme Inhibitors | 2 | 2010 | 827 | 0.100 |
Why?
| | Extracellular Matrix | 1 | 2016 | 503 | 0.100 |
Why?
| | Acetic Anhydrides | 1 | 2011 | 3 | 0.100 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 213 | 0.100 |
Why?
| | Transfection | 2 | 2004 | 911 | 0.100 |
Why?
| | Biomarkers | 3 | 2016 | 3972 | 0.100 |
Why?
| | RNA Interference | 1 | 2013 | 448 | 0.090 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2005 | 11 | 0.090 |
Why?
| | Microscopy, Confocal | 2 | 2004 | 310 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 582 | 0.090 |
Why?
| | Chromatography, Gel | 2 | 2005 | 127 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2015 | 413 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2013 | 372 | 0.090 |
Why?
| | Insulin | 3 | 2008 | 2325 | 0.090 |
Why?
| | Cell Membrane | 2 | 2005 | 732 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2011 | 99 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 958 | 0.090 |
Why?
| | Dogs | 3 | 2005 | 381 | 0.090 |
Why?
| | Glutamine | 1 | 2011 | 98 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 372 | 0.090 |
Why?
| | Female | 11 | 2024 | 68686 | 0.090 |
Why?
| | Base Sequence | 2 | 2015 | 2142 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 505 | 0.090 |
Why?
| | Drug Antagonism | 1 | 2010 | 10 | 0.090 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 24 | 0.090 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 84 | 0.080 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 38 | 0.080 |
Why?
| | Edetic Acid | 1 | 2009 | 46 | 0.080 |
Why?
| | Resins, Synthetic | 1 | 2009 | 14 | 0.080 |
Why?
| | Buffers | 1 | 2009 | 56 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2010 | 26 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 1 | 2010 | 55 | 0.080 |
Why?
| | Caspase Inhibitors | 1 | 2010 | 83 | 0.080 |
Why?
| | DNA Primers | 1 | 2010 | 510 | 0.080 |
Why?
| | Surface Properties | 1 | 2010 | 399 | 0.080 |
Why?
| | Umbilical Veins | 2 | 2008 | 61 | 0.080 |
Why?
| | Alzheimer Disease | 2 | 2010 | 519 | 0.080 |
Why?
| | Myosin Type II | 1 | 2008 | 16 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1196 | 0.080 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 161 | 0.080 |
Why?
| | Homoarginine | 1 | 2008 | 2 | 0.070 |
Why?
| | Methylurea Compounds | 1 | 2008 | 7 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 901 | 0.070 |
Why?
| | Oxygen | 2 | 2005 | 911 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 318 | 0.070 |
Why?
| | Doxorubicin | 1 | 2010 | 325 | 0.070 |
Why?
| | Antibodies | 2 | 2000 | 398 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2009 | 1083 | 0.070 |
Why?
| | Macular Degeneration | 1 | 2009 | 159 | 0.070 |
Why?
| | Receptors, Immunologic | 1 | 2008 | 216 | 0.070 |
Why?
| | Fatty Acids | 1 | 2010 | 427 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1037 | 0.070 |
Why?
| | Frameshift Mutation | 1 | 2007 | 32 | 0.070 |
Why?
| | Protein Subunits | 1 | 2008 | 234 | 0.070 |
Why?
| | Rabbits | 2 | 1998 | 778 | 0.070 |
Why?
| | Carbonic Anhydrases | 1 | 2006 | 14 | 0.060 |
Why?
| | Hemocyanins | 1 | 2005 | 62 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2007 | 282 | 0.060 |
Why?
| | Iodides | 1 | 2005 | 6 | 0.060 |
Why?
| | Myristic Acids | 1 | 2005 | 7 | 0.060 |
Why?
| | Ninhydrin | 1 | 2005 | 1 | 0.060 |
Why?
| | Fructose | 1 | 2005 | 106 | 0.060 |
Why?
| | Diffusion | 1 | 2005 | 117 | 0.060 |
Why?
| | Rats, Inbred BN | 1 | 2025 | 58 | 0.060 |
Why?
| | Cytoplasm | 1 | 2005 | 263 | 0.060 |
Why?
| | Erythrocytes | 2 | 2017 | 672 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2010 | 1901 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2024 | 34 | 0.060 |
Why?
| | Acetylcysteine | 1 | 2005 | 146 | 0.060 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 2003 | 10 | 0.050 |
Why?
| | Alcohol Dehydrogenase | 1 | 2003 | 16 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2005 | 177 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3079 | 0.050 |
Why?
| | Mitochondria | 1 | 2010 | 877 | 0.050 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2003 | 89 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 274 | 0.050 |
Why?
| | Antigens | 1 | 2005 | 355 | 0.050 |
Why?
| | Galectin 3 | 1 | 2003 | 20 | 0.050 |
Why?
| | Semicarbazides | 1 | 2002 | 1 | 0.050 |
Why?
| | Up-Regulation | 1 | 2006 | 839 | 0.050 |
Why?
| | Serum Albumin, Bovine | 2 | 2000 | 63 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 312 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 31 | 0.050 |
Why?
| | Retinal Neovascularization | 1 | 2002 | 25 | 0.050 |
Why?
| | Reference Values | 2 | 1996 | 793 | 0.050 |
Why?
| | Oligopeptides | 1 | 2004 | 256 | 0.050 |
Why?
| | Child | 4 | 2015 | 20868 | 0.050 |
Why?
| | Deoxyribose | 1 | 2001 | 6 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2001 | 62 | 0.050 |
Why?
| | Serum Albumin, Human | 1 | 2000 | 6 | 0.040 |
Why?
| | Molecular Weight | 2 | 1991 | 331 | 0.040 |
Why?
| | Hyperglycemia | 1 | 2004 | 328 | 0.040 |
Why?
| | Color | 1 | 2001 | 71 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2008 | 2391 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2001 | 128 | 0.040 |
Why?
| | Guanidines | 2 | 1997 | 36 | 0.040 |
Why?
| | Chelating Agents | 1 | 2000 | 68 | 0.040 |
Why?
| | Carbohydrates | 1 | 2000 | 64 | 0.040 |
Why?
| | Muramidase | 1 | 2000 | 77 | 0.040 |
Why?
| | Uremia | 2 | 2008 | 14 | 0.040 |
Why?
| | Aorta | 1 | 2002 | 411 | 0.040 |
Why?
| | Aldehydes | 1 | 2001 | 143 | 0.040 |
Why?
| | Alkanes | 1 | 1999 | 14 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1999 | 137 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 1998 | 48 | 0.040 |
Why?
| | Amides | 1 | 1999 | 91 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 821 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1287 | 0.040 |
Why?
| | Glyceraldehyde | 1 | 1997 | 2 | 0.040 |
Why?
| | Photosensitizing Agents | 1 | 1997 | 31 | 0.030 |
Why?
| | Spectrometry, Mass, Fast Atom Bombardment | 1 | 1996 | 7 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1382 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2017 | 218 | 0.030 |
Why?
| | Glycosuria | 1 | 1996 | 8 | 0.030 |
Why?
| | Aminocaproates | 1 | 1995 | 2 | 0.030 |
Why?
| | Neurofilament Proteins | 1 | 1996 | 43 | 0.030 |
Why?
| | Scattering, Radiation | 1 | 2015 | 100 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2014 | 31 | 0.030 |
Why?
| | Galactitol | 1 | 1994 | 1 | 0.030 |
Why?
| | Complement Activation | 1 | 2017 | 376 | 0.030 |
Why?
| | Galactose | 1 | 1994 | 28 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1106 | 0.030 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1993 | 51 | 0.030 |
Why?
| | Child, Preschool | 1 | 2007 | 10516 | 0.020 |
Why?
| | Pronase | 1 | 1992 | 5 | 0.020 |
Why?
| | Diabetic Neuropathies | 1 | 1993 | 96 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3375 | 0.020 |
Why?
| | Pigmentation | 1 | 1991 | 51 | 0.020 |
Why?
| | Hydrolysis | 1 | 1991 | 186 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 368 | 0.020 |
Why?
| | Fluorometry | 1 | 2009 | 17 | 0.020 |
Why?
| | NADPH Oxidase 4 | 1 | 2008 | 8 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 37 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 38 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2008 | 108 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2008 | 135 | 0.020 |
Why?
| | Diet | 1 | 1994 | 1212 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 474 | 0.020 |
Why?
| | NF-kappa B | 1 | 2008 | 653 | 0.010 |
Why?
| | Hippocampus | 1 | 2010 | 874 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2008 | 845 | 0.010 |
Why?
| | Logistic Models | 1 | 2009 | 1986 | 0.010 |
Why?
| | Endothelium, Corneal | 1 | 2003 | 16 | 0.010 |
Why?
| | Epiretinal Membrane | 1 | 2002 | 7 | 0.010 |
Why?
| | Retinal Vasculitis | 1 | 2002 | 10 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2003 | 315 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 213 | 0.010 |
Why?
| | Photochemistry | 1 | 2002 | 131 | 0.010 |
Why?
| | Autoantibodies | 1 | 2009 | 1466 | 0.010 |
Why?
| | Cell Communication | 1 | 2003 | 301 | 0.010 |
Why?
| | Neurons | 1 | 2010 | 1511 | 0.010 |
Why?
| | Amines | 1 | 1997 | 38 | 0.010 |
Why?
| | Alkalies | 1 | 1996 | 8 | 0.010 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 1996 | 22 | 0.010 |
Why?
| | Densitometry | 1 | 1996 | 34 | 0.010 |
Why?
| | Guanidine | 1 | 1996 | 22 | 0.010 |
Why?
| | Cell Fractionation | 1 | 1996 | 56 | 0.010 |
Why?
| | Formates | 1 | 1996 | 13 | 0.010 |
Why?
| | Endopeptidases | 1 | 1996 | 87 | 0.010 |
Why?
| | Urea | 1 | 1996 | 77 | 0.010 |
Why?
| | Hemostatics | 1 | 1996 | 49 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1996 | 426 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 305 | 0.010 |
Why?
| | Peritoneal Dialysis | 1 | 1996 | 95 | 0.010 |
Why?
| | Renal Dialysis | 1 | 1996 | 423 | 0.010 |
Why?
| | Axons | 1 | 1993 | 191 | 0.010 |
Why?
| | Kidney Failure, Chronic | 1 | 1996 | 547 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 1993 | 2436 | 0.000 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 1993 | 3628 | 0.000 |
Why?
|
|
Nagaraj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|